Table 3.
Dependent variables | Independent variables | B | P value | R2 total model |
---|---|---|---|---|
Fat malabsorption (total) | Genotype (WT = 0) | −0.85 | 0.29 | 0.24 |
Treatment (control = 0) | −1.0 | 0.25 | ||
Gender (female = 0) | 0.9 | 0.33 | ||
Fat malabsorption (saturated) | Genotype (WT = 0) | 0.08 | 0.96 | 0.25 |
Treatment (control = 0) | −2.3 | 0.13 | ||
Gender (female = 0) | 1.7 | 0.27 | ||
Fat malabsorption (unsaturated) | Genotype (WT = 0) | −1.0 | 0.19 | 0.24 |
Treatment (control = 0) | −0.64 | 0.41 | ||
Gender (female = 0) | 0.74 | 0.34 | ||
Fecal bile salt excretion (total) | Genotype (WT = 0) | 7.4 | <0.001a | 0.83 |
Treatment (control = 0) | −5.1 | 0.006a | ||
Gender (female = 0) | −7.1 | <0.001a | ||
Fecal bile salt excretion (primary) | Genotype (WT = 0) | 9.7 | <0.001a | 0.77 |
Treatment (control = 0) | −4.0 | 0.06 | ||
Gender (female = 0) | −5.9 | 0.01a | ||
Fecal bile salt excretion (secondary) | Genotype (WT = 0) | −2.5 | 0.06 | 0.34 |
Treatment (control = 0) | −1.1 | 0.37 | ||
Gender (female = 0) | −1.2 | 0.34 | ||
Body weight | Genotype (WT = 0) | −3.2 | 0.004a | 0.85 |
Treatment (control = 0) | 0.8 | 0.51 | ||
Gender (female = 0) | 8.1 | <0.001a | ||
Gender × treatment | −5.3 | 0.01a | ||
Area under the curve 1-13C-palmitin | Genotype (WT = 0) | −2.2 | 0.9 | 0.46 |
Treatment (control = 0) | 63.8 | 0.03a | ||
Gender (female = 0) | 0.29 | 0.29 | ||
Area under the curve 1-13C-stearate | Genotype (WT = 0) | −8.4 | 0.77 | 0.33 |
Treatment (control = 0) | 55 | 0.09 | ||
Gender (female = 0) | −3.5 | 0.9 |
B, unstandardized β coefficient; R2, regression correlation coefficient; WT, wild-type.
Statistically significant.